N-glycosylation humanization for production of therapeutic recombinant glycoproteins in saccharomyces cerevisiae

Methods in Molecular Biology

Volumn 988, Issue , 2013, Pages 45-57

  Arico, Christelle ^a   Bonnet, Christine ^a   Javaud, Christophe ^a  

^a Glycode SAS ^*  (France)

Author keywords

Glycoengineering; Glycosylation; Homologous recombination; Saccharomyces cerevisiae

Indexed keywords

ADENINE; ADENINE 2; CANAVANINE; CANAVANINE 1; FORMYLPEPTIDE RECEPTOR LIKE 1; GLYCAN; GLYCOPROTEIN; LYSINE; LYSINE 2; MANNOSYLTRANSFERASE; METHIONINE; METHIONINE 17; METHIONINE 28; RECOMBINANT GLYCOPROTEIN; RECOMBINANT PROTEIN; TRYPTOPHAN; TRYPTOPHAN 1; UNCLASSIFIED DRUG; URACIL; URACIL 3; HYBRID PROTEIN; MEMBRANE PROTEIN; MNN1 PROTEIN, S CEREVISIAE; OCH1 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN;

ARTICLE; AUXOTROPHY; CULTURE MEDIUM; GENE EXPRESSION; GENE EXPRESSION SYSTEM; HOMOLOGOUS RECOMBINATION; HUMAN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; SACCHAROMYCES CEREVISIAE; BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; GENE DELETION; GENETIC TRANSFORMATION; GENETICS; GLYCOSYLATION; METABOLISM; MOLECULAR GENETICS; PROTEIN ENGINEERING;

CARBOHYDRATE SEQUENCE; GENE DELETION; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MANNOSYLTRANSFERASES; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSFORMATION, GENETIC;

EID: 84882966115     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-327-5_4     Document Type: Article

References (20)

1. http://www.fda.gov/Food/FoodIngredientsPackaging/ucm078956.htm
2. Liu Z, Tyo K, Martinez JL, Petranovic D, Nielsen J (2012) Different expression systems for production of recombinant proteins in Saccharomyces cerevisiae. Biotechnol Bioeng 109(5):1259-1268, http:/dx.doi.org/10.1002/bit. 244009
3. Kim HJ, Lee SJ, Kim HJ (2010) Optimizing the secondary structure of human papillomavirus type 16L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae. J Biotechnol 150: 31-36
4. Rakestraw JA, Sazinsky SL, Piatesi A, Antipov E, Wittrup KD (2009) Directed evolution of a secretory leader for the improved expression of heterologous proteins and full length antibodies in Saccharomyces cerevisiae. Biotechnol Bioeng 103: 1192-1201
5. Higuchi M, Oh-eda M, Kuboniwa H, Tomonoh K, Shimonaka Y, Ochi N (1992) Role of sugar chains in the expression of the biological activity of human erythropoietin. J Biol Chem 267: 7703-7709
6. Fujihara J, Yasuda T, Kunito T, Fujii Y, Takatsuka H, Moritani T, Takeshita H (2008) Two N -linked glycosylation sites (Asn18 and Asn106) are both required for full enzymatic activity, thermal stability, and resistance to proteolysis in mammalian deoxyribonuclease I. Biosci Biotechnol Biochem 72: 3197-3205
7. Jez J, Antes B, Castilho A, Krainer M, Wiederkum S, Grass J, Rüker F, Woisetschläger M, Steinkellner H (2012) Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments. J Biol Chem 287: 24313-24319
8. Böhm S, Schwab I, Lux A, Nimmerjahn F (2012) The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol 34: 443-453
9. Kniskern PJ, Hagopian A, Burke P, Schultz LD, Montgomery DL, Hurni WM, Ip YC, Schulman CA, Maigetter RZ, Wampler DE, Kubek D, Sitrin RD, West DJ, Ellis RW, Miller WJ (1994) Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N -linked hyperglycosylation. Vaccine 12: 1021-1025
10. Lam JS, Mansour MK, Specht CA, Levitz SM (2005) A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 175(11): 7496-7503
11. Yan A, Lennarz WJ (2005) Unraveling the mechanism of protein N -glycosylation. J Biol Chem 280(5): 3121-3124
12. Lehle L, Strahl S, Tanner W (2006) Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. Angew Chem Int Ed Engl 45: 6802-6818
13. Schiestl M, Stangler T, Torella C, Cepeljnik T, Toll H, Grau R (2011) Acceptable changes in quality attributes of glycosylated biopharmaceuticals. Nat Biotechnol 29: 310-312
14. Nakayama K, Nagasu T, Shimma Y, Kuromitsu J, Jigami Y (1992) OCH1 encodes a novel membrane bound mannosyltransferase: outer chain elongation of asparagine-linked oligosaccharides. EMBO J 11: 2511-2519
15. Nakanishi-Shindo Y, Nakayama K, Tanaka A, Toda Y, Jigami Y (1993) Structure of the N -linked oligosaccharides that show the complete loss of alpha-1, 6-polymannose outer chain from och1, och1 mnn1, and och1 mnn1 alg3 mutants of Saccharomyces cerevisiae. J Biol Chem 268: 26338-26345
16. Lehle L, Eiden A, Lehnert K, Haselbeck A, Kopetzki E (1995) Glycoprotein biosynthesis in Saccharomyces cerevisiae: ngd29, an N -glycosylation mutant allelic to och1 having a defect in the initiation of outer chain formation. FEBS Lett 370: 41-45
17. Nakayama K, Nakanishi-Shindo Y, Tanaka A, Haga-Toda Y, Jigami Y (1997) Substrate specificity of alpha-1, 6-mannosyltransferase that initiates N -linked mannose outer chain elongation in Saccharomyces cerevisiae. FEBS Lett 412: 547-550
18. Wach A, Brachat A, Pöhlmann R, Philippsen P (1994) New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10: 1793-1808
19. Nagasu T, Shimma Y, Nakanishi Y, Kuromitsu J, Iwama K, Nakayama K, Suzuki K, Jigami Y (1992) Isolation of new temperature-sensitive mutants of Saccharomyces cerevisiae deficient in mannose outer chain elongation. Yeast 8: 535-547
20. Johnston M (1987) A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev 51: 458-476